EssilorLuxottica, FR0000121667

Nuance Audio Plus launches as EssilorLuxottica stock sits 55.00 percent below its high

Published on 10/02/2026 at 15:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nuance Audio Plus starts at USD 829 in the United States. EssilorLuxottica stock costs EUR 145.70 on October 2, 2026 versus EUR 144.95.

Modernes Konzerngebäude mit Glasfassade, Architektur-Render
EssilorLuxottica FR0000121667 repräsentiert modernes Konzerngebäude mit Glasfassade als architektonisches Render eines europäischen Hauptquartiers, Illustration mit AI erstellt.

EssilorLuxottica (ISIN FR0000121667) was trading at EUR 145.70 at Lang & Schwarz on October 2, 2026 at 3:37 p.m. CEST, up 0.52 percent versus the EUR 144.95 prior close. The company launched Nuance Audio Plus on September 29, 2026, while the stock stood 55.00 percent below its EUR 323.80 52-week high. Morningstar reports that the new hearing glasses start at USD 829 in the United States.

Nuance Audio targets hearing care

Nuance Audio Plus combines open-ear hearing support with prescription eyewear and offers extended battery life of 10 hours under average product conditions. The product is available through authorized optical and hearing-care professionals and online in selected countries.

The launch adds a fresh product milestone to EssilorLuxottica's medical-device strategy. The company said the first Nuance Audio glasses had expanded to 14 countries and more than 18,000 stores in one year, giving the new version an established distribution base.

AI glasses expand the growth platform

On September 24, 2026, EssilorLuxottica and Meta unveiled a camera-free Ray-Ban Meta Audio line and the third generation of Ray-Ban Meta. The partnership is set to offer more than 100 AI-glasses styles by the end of 2026, extending the company's exposure to connected eyewear.

The operating backdrop was also quantified in the first half of 2026. In its results call, Yahoo Finance reported revenue growth of 9.7 percent at constant currency, adjusted operating profit growth of 15.00 percent and EUR 1.067 billion in free cash flow. The cash figure was more than EUR 100 million above the comparable first-half figure, creating a concrete counterweight to the stock's valuation compression.

Targets remain far above the price

Analyst expectations remain widely separated from the market quote. According to MarketScreener on September 22, 2026, RBC kept its Buy rating but cut its target from EUR 230.00 to EUR 190.00. The revised target lies 30.40 percent above the Lang & Schwarz price.

The next company event listed by EssilorLuxottica is the start of the quiet period on October 6, 2026, ahead of the third-quarter revenue release. The company's investor page also identifies Euronext Paris as the listing venue, while EssilorLuxottica is included in the CAC 40 and Euro Stoxx 50.

Stock remains below its yearly high

At EUR 145.70, the Lang & Schwarz quote was EUR 7.40 above the EUR 138.30 52-week low and EUR 178.10 below the EUR 323.80 high on October 2, 2026. The daily move was plus 0.52 percent versus the EUR 144.95 prior close, leaving the market reaction modest despite the product launches and first-half cash generation.

The further course of trading is shown by the continuously updated real-time quote of EssilorLuxottica stock.

EssilorLuxottica stock facts

  • Company: EssilorLuxottica S.A.
  • ISIN: FR0000121667
  • Ticker: EL
  • Primary exchange: Euronext Paris
  • Price Lang & Schwarz as of October 2, 2026, 3:37 p.m. CEST: EUR 145.70
  • Change versus prior close: plus 0.52 percent
  • Prior close Lang & Schwarz October 1, 2026: EUR 144.95
  • Market capitalization: EUR 66.9 billion as of October 2, 2026
  • 52-week range: EUR 138.30-323.80 as of October 2, 2026
  • Sector / Industry: Healthcare / Medical Instruments and Supplies
  • Index membership: CAC 40 and Euro Stoxx 50

More news and analyses on EssilorLuxottica stock

Disclaimer...

en | FR0000121667 | ESSILORLUXOTTICA | boerse | 70216019 | bgmi